Skip to Content
Merck
  • Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.

Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.

The Journal of biological chemistry (2016-09-30)
Mindy I Davis, Rajan Pragani, Jennifer T Fox, Min Shen, Kalindi Parmar, Emily F Gaudiano, Li Liu, Cordelle Tanega, Lauren McGee, Matthew D Hall, Crystal McKnight, Paul Shinn, Henrike Nelson, Debasish Chattopadhyay, Alan D D'Andrea, Douglas S Auld, Larry J DeLucas, Zhuyin Li, Matthew B Boxer, Anton Simeonov
ABSTRACT

Deubiquitinases are important components of the protein degradation regulatory network. We report the discovery of ML364, a small molecule inhibitor of the deubiquitinase USP2 and its use to interrogate the biology of USP2 and its putative substrate cyclin D1. ML364 has an IC

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Thymidine 5′-triphosphate sodium salt, ≥96%
Sigma-Aldrich
Anti-MDM2 (Ab-1) Mouse mAb (IF2), liquid, clone IF2, Calbiochem®
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
ML364, ≥98% (HPLC)